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Abstract
Background: Although fatal opioid poisonings tripled from 1999 to 2008, data describing nonfatal poisonings are
rare. Public health authorities are in need of tools to track opioid poisonings in near real time.
Methods: We determined the utility of ICD-9-CM diagnosis codes for identifying clinically significant opioid
poisonings in a state-wide emergency department (ED) surveillance system. We sampled visits from four hospitals
from July 2009 to June 2012 with diagnosis codes of 965.00, 965.01, 965.02 and 965.09 (poisoning by opiates and
related narcotics) and/or an external cause of injury code of E850.0-E850.2 (accidental poisoning by opiates and
related narcotics), and developed a novel case definition to determine in which cases opioid poisoning prompted
the ED visit. We calculated the percentage of visits coded for opioid poisoning that were clinically significant and
compared it to the percentage of visits coded for poisoning by non-opioid agents in which there was actually
poisoning by an opioid agent. We created a multivariate regression model to determine if other collected triage
data can improve the positive predictive value of diagnosis codes alone for detecting clinically significant opioid
poisoning.
Results: 70.1 % of visits (Standard Error 2.4 %) coded for opioid poisoning were primarily prompted by opioid
poisoning. The remainder of visits represented opioid exposure in the setting of other primary diseases. Among
non-opioid poisoning codes reviewed, up to 36 % were reclassified as an opioid poisoning. In multivariate analysis,
only naloxone use improved the positive predictive value of ICD-9-CM codes for identifying clinically significant
opioid poisoning, but was associated with a high false negative rate.
Conclusions: This surveillance mechanism identifies many clinically significant opioid overdoses with a high
positive predictive value. With further validation, it may help target control measures such as prescriber education
and pharmacy monitoring.
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Background
Opioid poisonings have risen precipitously from the
1980s through the 2000s, especially in the south-eastern
United States, overtaking motor vehicle collisions as the
leading cause of unintentional injury death [1–4]. In
2010, there were 25,036 opioid poisoning-related emer-
gency department (ED) visits in North Carolina (NC),
using International Classification of Disease, 9th edition
Clinical Modification (ICD-9-CM) diagnosis and exter-
nal cause codes [2]. These figures were almost twofold
higher than extrapolations of estimated poisonings from
the United States National Electronic Injury Surveillance
System (NEISS) [5]. While NEISS is useful for state-level
estimates and comparisons of injury and poisoning rates,
it does not have the level of detail that is helpful for state
public health workers for planning prevention activities.
For instance, in 2010, ED visit rates for poisonings had
almost tenfold variation between counties, ranging from
4 to 39 ED visits per 10,000 person-years [2]. There is
an urgent need for validated tools to track the incidence
of nonfatal poisonings.
The NC Disease Event Tracking and Epidemiologic
Collection Tool (NC DETECT) collects ICD-9-CM
codes and triage data from visits to all 24/7 civilian acute
care EDs [6]. The ability of NC DETECT to distinguish
the primary cause of an ED visit is often limited because
ED visits contain multiple diagnosis codes and it is diffi-
cult to interpret the severity or clinical significance of
the conditions referenced those codes alone. NEISS, in
contrast, collects data directly from a national represen-
tative sample of US EDs. Data are entered directly by a
trained NEISS representative at each hospital for all
reportable injuries in the system, which are determined
by a Division of the United States Consumer Product
Safety Commission [7] rather than being derived from
ICD-9-CM codes. Similar data are collected from a sam-
ple of EDs in the United States Drug Abuse Warning
Network (DAWN) [8]. This may explain the higher esti-
mates for opioid poisoning in NC DETECT relative to
estimates from NEISS or DAWN.
The definition of acute opioid poisoning for disease
surveillance has not been clearly established. In public
health surveillance, the CDC Guidelines Working Group
states that a surveillance system’s utility is determined in
part by the degree to which it provides “an improved
understanding of public health implications” of adverse
health-related events [9]. Most current definitions are not
aimed at this type of utility. ICD-9-CM codes 965.** rely
on medical coders’ transcription of the diagnosis based on
primary clinician documentation [6]. In contrast, DAWN
identifies cases using an algorithmic approach but divides
cases into overmedication (in which the clinician docu-
mented that the patient exceeded a prescribed or recom-
mended dose), adverse reaction (in which the clinician
attributed symptoms to a drug side effect), or other tox-
icity, which do not necessarily correspond to ICD-9-CM
coding [10]. The aim of the current initiative was to create
a case definition of clinically significant opioid poisoning
for surveillance purposes (i.e., those cases in which opioid
poisoning prompted an ED visit) and to assess the degree
to which ICD-9-CM codes for opioid poisoning correctly
identify these opioid poisonings.
Methods
Ethics and data use statement
This work was considered exempt from IRB review by
the University of North Carolina IRB (12–0448) and by
the Duke University IRB (Pro00047085) as a quality
improvement initiative. The data used were abstracted
from patient charts and thus were not publicly available.
Data access was granted by the IRBs and research units
of the respective institutions.
Case definition
ED visits containing one or more of the ICD-9-CM diag-
nosis codes listed in Table 1 were characterized as either
opioid poisoning-related or non-opioid poisoning-related
based on the diagnosis code. Non-opioid poisoning diag-
nosis codes were included as a comparison group.
Using collaborative input from epidemiologists and
emergency physicians, the authors developed a case def-
inition a priori for clinically significant opioid poisoning
and a record review algorithm to efficiently assess
whether a case could be considered clinically significant.
We defined a visit as a “clinically significant opioid poi-
soning” if in the judgment of the reviewers, the ED visit
would have been averted had the patient not consumed
the opioid. In cases of unclear causality (i.e., multiple
drugs taken), visits were coded as opioid poisoning un-
less there was documentation that the primary clinician
felt the dose of opioid consumed was too low to have
generated the patient’s symptoms. Cases in which the
medical decision-making indicated either the clinician’s
doubt about whether the patient’s symptoms were due
to opioid poisoning, or the clinician’s impression that
another agent was primarily responsible for the patient’s
symptoms, were not classified as clinically significant
poisonings. An algorithm standardized the interpretation
of classification of opioid poisoning events (Fig. 1). Be-
cause a few patients in the sample had an extended serum
opioid toxicology panel sent for analysis, any toxicology
test positive for opioids was considered positive for the
purposes of the algorithm.
Data collection
Institutional ED discharge records were used to identify
all patients presenting between July 1 2009 and June 30,
2012 at two tertiary care University EDs (University
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Hospital 1 and 2) and two secondary care Community
EDs (both affiliated with University Hospital 2) with opi-
oid poisoning-related diagnosis codes (Table 1). General
codes such as 965 (without a decimal modifier) were not
queried due to lack of specificity. Due to the large number
of cases at University Hospital 2, the authors conducted a
simple random sample using JMP 11 (SAS Institute, Cary,
NC) to select cases for review. We did not perform inde-
pendent power calculations for each hospital as three of
the hospitals included the entire sample population at
their hospital. During the dates sampled, no hospital was
undergoing any changes in electronic medical record sys-
tems, coding or billing processes. Each hospital sampled
uses a staff of professional coders and computer-assisted
coding. Data were abstracted independently by two resi-
dent physicians (JMR and GCS) who each reviewed the
data abstraction method prior to the study. Clinicians
reviewed the free text ED visit note, lab tests ordered,
psychiatric consult note, and inpatient discharge summary
(if applicable) for each visit. Data evaluated included
reported history of drug poisoning, patient disposition
(hospital admission or discharge), clinical symptoms,
toxicology screen results, insurance status, and associ-
ated diagnosis codes.
A sample of poisoning-related ED visits that were
not billed for opioid poisoning from University Hos-
pital 1 was also reviewed for false negatives, including
all cases with code 909.*, every other case with code
977.9, every 20th case with code 304.0 or 304.7, and
every 10th case with code 305.5, using sequential se-
lection (Table 1).
A standardized reporting form on Excel 2013 was used
to abstract data from each visit. Data were entered into
Excel 2013 (Microsoft, Redmond, WA, USA) and were
analysed with JMP 11 (SAS Institute, Cary, NC, USA)
and SAS 9.3 (ibid.).
Table 1 ICD-9-CM diagnosis codes included in ED visit sample
Opioid poisoning-related diagnosis codes Non-opioid poisoning-related diagnosis codes
Poisoning by opium, unspecified (965.00) Late effect of poisoning due to drug, medicinal or biological substances (909.0)
Poisoning by heroin (965.01) Poisoning by other specified drugs and medicinal substances (977.9)
Poisoning by methadone (965.02) Drug dependence (304)
Poisoning by other opiates or related narcotics (965.09) Opioid abuse (305.5)
Accidental poisoning by heroin (E850.0)
Accidental poisoning by methadone (E850.1)
Accidental poisoning by other opiates or related narcotics (E850.2)
Fig. 1 9pt?>Decision tree for identifying clinically significant opioid poisoning in emergency department visits coded as opioid poisoning. *History of Present
Illness was positive for opioid poisoning if it included signs of opioid poisoning (altered mental status or respiratory depression) after an opioid ingestion
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Data analysis
Each data abstractor independently assessed whether the
primary reason for the visit was an opioid poisoning.
Discrepancies were arbitrated by mutual consensus, with
a third reviewer (CAS) to resolve any persistent dis-
agreement. Kappa statistics were generated to measure
agreement between the first two abstractors.
A multiple regression model was built using data from
University Hospital 1 in order to seek a more specific
definition of opioid poisoning. The independent variables
included in the model were patient age, sex, use of nalox-
one by EMS or hospital personnel referenced in the triage
note, number of ICD-9-CM codes generated, and ordinal
position of the opioid-related diagnosis code within the
submitted ICD-9-CM code list, and the dependent vari-
able was clinically significant opioid poisoning. The or-
dinal position of the ICD-9 code within the ICD-9-CM
code list was not available using the medical record
abstraction system at the other hospitals and they were
not included in the multiple regression.
Results
There were 136 patient visits at University Hospital 1,
63 visits at Community Hospital 1, and 19 visits at Com-
munity Hospital 2 that were coded for opioid poisoning
(965 series and/or E850 modifiers), of which all charts
were reviewed. At University Hospital 2, there were 236
visits with a code for opioid poisoning, of which 141
charts were randomly sampled. Summary statistics of
these visits are shown in Table 2. Weighted statistics
were calculated, adjusting for the random sampling at
University Hospital 2, by multiplying the proportions
measured in University Hospital 2 by the total number
of visits observed over the number of visits sampled
(236/141), so that final statistics reflect the whole popu-
lation of the two health systems over the study period.
Overall, 70.1 % (Standard Error 2.4 %) of ED visits
receiving a 965 series code were determined to be clinic-
ally significant opioid poisoning (the positive predictive
value). Standard Error was used to describe the estimate
variability because random sampling was employed at
University Hospital 2. At University Hospital 1, 18 % of
reviewed ED visits that contained a code for poisoning
by a non-opioid agent alone were nonetheless deter-
mined to be opioid poisonings (Table 3). Among the 136
patients coded for opioid poisoning at University Hos-
pital 1, 3 % had both a history negative for opioid inges-
tion and a negative toxicologic screening. There was
considerable variation between the hospitals in the other
characteristics examined including percent of cases with
a chief complaint of poisoning, percent of cases in which
naloxone was administered, and percent of cases admit-
ted to the hospital. Kappa statistics for inter-rater agree-
ment between data abstractors were 0.58 for University
Hospital 1, 0.74 for University Hospital 2, 0.78 for Com-
munity Hospital 1 and 0.43 for Community Hospital 2.
In multiple logistic regression, only naloxone use was
associated with clinically significant opioid poisoning (p
< .0001). Overall, 25 % of opioid poisonings determined
to be clinically significant received naloxone and 12 % of
those not determined to be clinically significant received
naloxone.
To assess the range of sensitivity of different parameters,
we calculated the positive predictive value of a case defin-
ition using the combination of a 965 series diagnosis code
and naloxone administration for predicting clinically sig-
nificant opioid poisoning among cases reviewed at all
three hospitals. This case definition increased the positive
predictive value to 84 % (n = 95 cases with both ICD-9-
CM code 965.* and naloxone administration), compared
with 46 % positive predictive value with naloxone admin-
istration alone (p < 0.05). However, the false negative rate
for the novel case definition was high (34 %).
Discussion
Here, we present the first data validating use of ICD-9-
CM codes from an ED to detect cases of clinically signifi-
cant opioid poisoning with reasonable positive predictive
value based on medical record review. Given the rapid rise
in the number of opioid poisonings, these systems may
help to identify locations in which patients are at risk from
opioid prescribing or distribution patterns.
Table 2 Demographics and proportion of clinically significant cases among opioid-related ED visits identified by opioid poisoning
965.00, 965.01, 965.02, 965.09 and E850.0-2 ICD-9-CM codes
University Hospital 1
(n = 136)
University Hospital 2
(n = 141)
Community Hospital 1
(n = 63)
Community Hospital 2
(n = 19)
Weighted percentage
Percent male 40 % 51 % 48 % 74 % 48 %
Mean age in years (SD) 43.4 (SD 20.1) 42.1 (SD 17.8) 44.1 (SD 19.2) 31.9 (SD 13.9) 42.3 (SD 10.5)
Percent with chief complaint
of poisoning
38 % 27 % 54 % 79 % 36 %
Percent admitted to hospital 70 % 64 % 49 % 26 % 62 %
Percent given naloxone 48 % 50 % 37 % 16 % 46 %
Clinically significant poisoning 70 % 72 % 71 % 74 % 70 %
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The ED serves as an ideal screening point to assess a
community for clinically significant overdoses as patients
with nonfatal poisoning and concerning symptoms are typ-
ically transported for medical evaluation. Our definition of
poisoning is easily applied to the ED setting across record
systems. Our data show that the majority of those ED visits
coded for opioid poisoning were determined to be clinic-
ally significant poisoning, and that incorporating free-text
searches of triage notes for naloxone administration can
improve the positive predictive value of the surveillance.
While few data exist in the literature to establish the
positive predictive value of ICD-9-CM codes for clinically
significant opioid poisoning, there is substantial variation
in ICD-9-CM codes’ ability to identify other injuries, ran-
ging from 64 to 85 % in a recent systematic review [11].
This broad range of accuracies may reflect more or less
strict case definitions for particular injuries or poisonings.
In the case of opioid poisoning, common coingestions and
associated causes of altered mental status (for instance,
cancer or chronic painful conditions) may cloud the pic-
ture of causality in deaths or adverse events. Prior studies
have suggested that patients with comorbid conditions
such as cancer may be at lower risk of death from opioid
poisoning despite high prescribed doses [12]. The coding
uncertainty around polypharmacy poisonings may also
contribute to the lowered utility of ICD-9-CM code sur-
veillance for poisonings [13].
The fact that no other factor predicted significant
poisoning in our sample reflects the heterogeneity of
opioid poisonings with respect to patient initial presen-
tation, demographics, and ultimate disposition, which
underscores that opioid poisoning cuts across societal
divisions and should be considered in any ED patient
with a suggestive history. The heterogeneity of hospital
admission rates and naloxone administration by hos-
pital likely points to the differing doses and routes of
opioid exposure rather than practice pattern variations,
as the hospitals are within closely linked health systems.
Distinguishing pure opioid poisoning from other complex
causes of respiratory and mental status alteration,
including cancer and chronic conditions, may be impos-
sible with the ICD-9-CM coding system.
Most notably, these data are derived from four EDs
in North Carolina. These departments may see dis-
proportionately complex cases of opioid poisonings
due to referral patterns toward University-affiliated
EDs, although there was remarkable consistency among
hospitals in our study.
The Kappa statistics for each hospital vary significantly.
We hypothesize that the Kappa statistic for University
Hospital 2 was higher than that for University Hospital 1
because the reviewers had greater familiarity with the case
definition from reviewing University Hospital 1 when they
began reviewing University Hospital 2. The low Kappa
statistics for Community Hospital 2 can be attributed
to that hospital’s unique checkbox-based record system
with minimal text (T-System, Dallas, TX, USA) and small
sample size.
Since this analysis was conducted on a retrospective
cohort of patients based on ICD-9-CM codes, we cannot
calculate a true sensitivity and specificity. We attempted
to account for this limitation by calculating the positive
predictive value of ICD-9-CM for identifying clinically
significant cases and by identifying the proportion of
opioid poisonings in a selection of cases with ICD-9-CM
codes for poisoning by other agents at University Hospital
1 (Table 3). Due to staff resource constraints, these other
ICD-9-CM codes were not reviewed at other hospitals.
Our data include only the first 11 ICD-9-CM diagnosis
codes generated from a given visit. While it is possible
that codes indicating a clinically significant opioid poi-
soning could appear beyond the 11th diagnosis code pos-
ition, it is probably not a common occurrence. However,
it is likely, particularly with polypharmacy poisonings,
that the opioid poisoning code may not be in the first
few diagnosis codes listed. To ensure a straightforward
case definition, reviewers relied on the clinician’s docu-
mented impression in the medical record of whether the
case constituted an opioid poisoning. While this ap-
proach avoided strict dose-based cut-offs, it allowed for
Table 3 Proportion of ED Visits at University Hospital 1 with non-opioid poisoning ICD-9-CM diagnosis codes that were determined
to be opioid-related
Code 909: Late effects of other & unspecified
external causes (n = 23)
977.9: Poisoning by unspecified
drug (n = 27)
304.0 or 304.7: Drug
dependence (n = 11)
305.5: Nondependent
opioid abuse (n = 17)
Percent male 48 % 37 % 55 % 35 %
Mean age in years (SD) 38.6 (16.9) 27 (16.5) 39.2 (14) 37.2 (12.7)
Percent admitted to hospital 70 % 48 % 73 % 47 %
Percent given naloxone 17 % 7 % 9 % 6 %
Percent with chief complaint
of poisoning
17 % 63 % 27 % 41 %
Percent Primary Opioid
Poisonings
30 % 22 % 0 % 6 %
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consideration of clinician judgment, which we believe to
be more important in real-life situations of uncertainty
around both opioid dose and patient response. This
algorithm can be flexibly adapted to the more-specific
codes contained in the upcoming ICD-10 (which convert
approximately to codes T40.1X, T40.2X, T40.3X, T40.60
and T40.69 for opioid poisoning, T50.901S for late effect
of poisoning due to drug, medicinal or biological sub-
stances, T50.90 for poisoning by other specified drugs
and medicinal substances, and F11-F19 for drug abuse
and dependence).
Conclusions
We conclude that, by using the ICD-9-CM codes available
in secondary data systems, a real time ED surveillance sys-
tem can reliably detect clinically significant opioid poison-
ings across hospital settings. Further work is needed to
establish the sensitivity and specificity of the system,
which likely varies by geographic context and provider
documentation patterns. The results of this study will be
used to inform opioid poisoning surveillance efforts using
NC DETECT. In future work, real-time ED data will allow
for timely investigations and interventions to mitigate
harm from geographic and temporal clusters of opioid
poisonings.
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